Accessibility helpSkip to navigationSkip to contentSkip to footer
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign In
  • Home
  • World
    Sections
    • World Home
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • Reeves has the best chance since Lloyd George of reforming property tax
    • A-level analysis shows London taking most top grades
    • Ukraine and Russia begin talks on exchange of prisoners captured in Kursk
    • US stocks rally as strong retail sales raise hopes of ‘soft landing’
    • The red state surprise about America’s green transition
  • US
    Sections
    • US Home
    • US Economy
    • Investing in America
    • US Companies
    • US Politics & Policy
    • US Presidential Election 2024
    Most Read
    • US stocks rally as strong retail sales raise hopes of ‘soft landing’
    • The red state surprise about America’s green transition
    • US eases tech curbs to boost Aukus security pact with UK and Australia
    • BDO sinks to bottom of US audit quality league table
    • Harris spends 10 times as much as Trump on digital ad blitz
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Reeves has the best chance since Lloyd George of reforming property tax
    • Citadel and DE Shaw slashed Nvidia holdings ahead of market rout
    • Starbucks’ new chief awarded $113mn pay deal and remote office in Newport Beach
    • US stocks rally as strong retail sales raise hopes of ‘soft landing’
    • Psychedelic medicine pioneer exits MDMA biotech after regulatory blow
  • Tech
    Sections
    • Tech Home
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
    Most Read
    • Harris spends 10 times as much as Trump on digital ad blitz
    • Google’s antitrust defeat could shape AI markets
    • English ChatGPT users flummoxed by language glitch as bot turns Welsh
    • In charts: Elon Musk’s megaphone reach on X
    • SoftBank discussed AI chips tie-up with Intel to rival Nvidia
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
    Most Read
    • Citadel and DE Shaw slashed Nvidia holdings ahead of market rout
    • US stocks rally as strong retail sales raise hopes of ‘soft landing’
    • Oslo struggles to solve ‘mystery’ of Norwegian krone’s decline
    • US farmers fear prospect of Trump tariffs will add to sector’s burdens
    • Kamala Harris should not cave to overtures from the crypto crowd
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Reeves has the best chance since Lloyd George of reforming property tax
    • The red state surprise about America’s green transition
    • Is Ikea more Dutch than Swedish?
    • Google’s antitrust defeat could shape AI markets
    • Renewables challenges blow Ørsted’s recovery off course
  • Lex
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
    Most Read
    • Starbucks’ new chief awarded $113mn pay deal and remote office in Newport Beach
    • How taking a holiday went global
    • Shareholders’ lawyers in $1bn Dell case clinch $267mn fee award
    • Starbucks hopes new CEO will bring ingredients of Chipotle’s success
    • Italy doubles tax for wealthy foreigners
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Lita, Marylebone: Am I good enough to eat here? — restaurant review
    • How taking a holiday went global
    • How to live the windmill fantasy
    • Do cars really need to roar?
    • Alien: Romulus — in space, no one can hear you yawn
  • HTSI
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Lex
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Disease control and prevention

  • Thursday, 15 August, 2024
    Mpox
    Vaccine bottlenecks pose risk to Mpox response as Sweden reports variant case

    Leading producer says it needs orders to ramp up supply with outbreaks surging in central and east Africa

    Dr Tresor Wakilongo verifies the evolution of skin lesions on the ear of a child with Mpox
  • Thursday, 15 August, 2024
    Helene Servillon
    US policymakers should embrace psychedelic medicine

    The Food and Drug Administration’s rejection of MDMA-assisted therapy is a missed opportunity

    Young woman with colourful psychoactive drug on her tongue
  • Wednesday, 14 August, 2024
    Mpox
    WHO declares mpox public health emergency as cases surge in Africa

    Global health body calls for action to tackle ‘very worrying’ outbreak of highly transmissible virus

    Montage of various viruses
  • Tuesday, 13 August, 2024
    Antibiotic resistance
    Urban birds may be spreading drug-resistant ‘superbugs’, research shows

    Wild birds are more likely to be carriers of antibiotic-resistant bacteria if they live close to humans, says study

    A duck leads 10 ducklings
  • Tuesday, 13 August, 2024
    Coronavirus
    This Covid effect won’t last for Asia’s antiviral stocks Premium content

    A surge in infections will boost companies’ shares but this sector’s volatility makes them a poor long-term bet

    Commuters in Tokyo wearing masks
  • Tuesday, 13 August, 2024
    Medical science
    EU rules threaten to cut new treatments for rare diseases

    Pharma groups and patients say guidance prioritising mass trials threaten drug development

    A doctor gives a patient a vaccination
  • Monday, 12 August, 2024
    National Health Service
    NHS launches ‘subscription’ scheme for antibiotics with pharma sector

    Drugmakers will receive flat fees for new medicines in push to avoid encouraging overuse

    Antibiotics are placed in petri dishes filled with bacteria
  • Wednesday, 7 August, 2024
    Medical science
    NHS in England to roll out £1.7mn Crispr gene editing drug

    Nice’s backing for Casgevy comes after UK became first country to give drug regulatory approval

    3d illustration of sickle cells in blood
  • Wednesday, 7 August, 2024
    Drugs research
    Eli Lilly enters nuclear isotope business to back cancer treatment

    Pharma companies are moving up the supply chain to secure radioactive materials for a new form of drugs

    Eli Lilly plant in New Jersey
  • Wednesday, 7 August, 2024
    Anjana Ahuja
    Rising rates of cancer in young people prompt hunt for environmental culprit

    That many of the cancers are gastrointestinal offers clues and could point to microplastics

    A man stands in the middle of red circle amid an even darker shade of red beyond that
  • Wednesday, 7 August, 2024
    Roche Holding AG
    Roche considers options for $1.9bn cancer data start-up

    Swiss drugmaker examines options for Flatiron Health after acquisition has disappointed

    Roche logo on the side of a building in Basel, Switzerland
  • Monday, 5 August, 2024
    Novo Nordisk AS
    Novo Nordisk spends record amounts on research to fend off weight-loss rivals

    Maker of Wegovy and Ozempic has 45,000 patients in clinical trials as it seeks to stave off threats from Eli Lilly and Roche

    A scientist holds a vial
  • Saturday, 3 August, 2024
    Neurotechnology
    Brain implant made from graphene is set to begin UK clinical trial

    Patients in Manchester will take part in first study using ‘wonder material’ that was discovered in the city

    An image of an InBrain cortical interface
  • Friday, 2 August, 2024
    The Big Read
    How medical research is failing women

    For years, the process for developing and testing new drugs has focused disproportionately on male bodies — to the detriment of female patients

  • Wednesday, 31 July, 2024
    Dementia
    High cholesterol critical factor in development of dementia, study finds

    Reducing 14 ‘modifiable’ risks can prevent or delay cognitive disorder, report says

    Doctor reviewing MRI scans
  • Tuesday, 30 July, 2024
    Anjana Ahuja
    Speedy sepsis test could save lives — but only if health systems can keep up

    The illness causes more deaths than strokes but a new time-saving technology may be able to help

    Andy Carter illustration of a hand holding a looking glass in the form of a ticking clock displaying germs in different colours
  • Monday, 29 July, 2024
    NHS watchdog blocks AstraZeneca breast cancer drug

    Nice blames cost for not recommending Enhertu, which has helped patients in clinical trials live longer

    Women demonstrate outside Parliament
  • Sunday, 28 July, 2024
    News in-depthMedical science
    The hunt for a rare nuclear isotope that could redefine cancer care

    Extreme shortages of actinium are holding up the promising field of radiopharmaceuticals

    President of Tuscany Eugenio Giani visits  the Monasterio Foundation in Pisa , which houses the the cyclotron of the Institute of Clinical Physiology of the National Research Council
  • Friday, 26 July, 2024
    Pharmaceuticals sector
    European Medicines Agency rejects breakthrough Alzheimer’s drug

    Eisai and Biogen face uphill battle to win EU approval for Leqembi after committee’s ruling

    Bottles and packages of the drug Leqembi
  • Friday, 26 July, 2024
    Gardens
    The secret Hong Kong garden that’s a portal to the past

    Chan Siun-kuen left rural China in the slipstream of the revolution for a rapidly urbanising Hong Kong. His herb garden restores a connection to forgotten traditions and the healing power of plants

    An entrance to a planting site at Lung Fu Shan Country Park, marked by a weathered wooden sign. The site is lush with various plants and trees, with a dirt path leading into the greenery
  • Thursday, 25 July, 2024
    Dementia
    Shingles vaccine ‘may prevent dementia’, research finds

    GSK’s Shingrix is latest drug to show potential for targeting previously untreatable brain disorders

    Shingrix shingles vaccine
  • Thursday, 25 July, 2024
    National Health Service
    NHS warns England has fewer than two days’ supply of vital O-negative blood

    Amber alert triggered as blood stocks fall to ‘unprecedentedly low levels’

    Mobile blood collection vehicles parked outside
  • Tuesday, 23 July, 2024
    Israel-Hamas war
    WHO warns Gaza at ‘high risk’ of polio outbreak

    Health organisation says the risk of transmission is high because of ‘the very dire situation with water sanitation’

  • Friday, 19 July, 2024
    Pharmaceuticals sector
    Diabetes device maker Embecta explores sale amid slowing profits

    Shares are down 70% for the world’s largest maker of insulin pen needles and syringes since it was spun off

    Insulin pen needles
  • Thursday, 18 July, 2024
    Novartis AG
    Novartis warns prostate cancer drug price will remain high

    Swiss drugmaker says it will only sell medication privately if health systems cannot pay

    A pedestrian passes by Novartis’ Institutes for Biomedical Research
Previous page You are on page 1 Next page

Join us at an FT Live event

Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

FT Live
Improving AML Patient Care
Tackling the cost burden of Acute Myeloid Leukaemia treatment
Thursday, 19 SeptemberDigital Conference
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Explore all events

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

Tools

PortfolioFT AppFT Digital EditionFT EditAlerts HubBusiness School RankingsSubscription ManagerNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2024. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Edition:International
UK
Subscribe for full access

Top sections

  • Home
  • World
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
  • US
    • US Economy
    • Investing in America
    • US Companies
    • US Politics & Policy
    • US Presidential Election 2024
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Lex
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Alphaville
  • FT Edit
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Visual and data journalism
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • FT Digital Edition
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In